Twist and p53 reciprocally regulate target genes via direct interaction

[1]  Y. Sasaguri,et al.  Clock and ATF4 transcription system regulates drug resistance in human cancer cell lines , 2007, Oncogene.

[2]  C. Glackin,et al.  N-cadherin gene expression in prostate carcinoma is modulated by integrin-dependent nuclear translocation of Twist1. , 2006, Cancer research.

[3]  H. Izumi,et al.  Transcription factors and drug resistance. , 2005, European journal of cancer.

[4]  V. Raman,et al.  HOXA5-Twist Interaction Alters p53 Homeostasis in Breast Cancer Cells* , 2005, Journal of Biological Chemistry.

[5]  A. Puisieux,et al.  Oncogenic cooperation between H-Twist and N-Myc overrides failsafe programs in cancer cells. , 2004, Cancer cell.

[6]  S. Ramaswamy,et al.  Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis , 2004, Cell.

[7]  H. Cheung,et al.  Identification of a novel function of TWIST, a bHLH protein, in the development of acquired taxol resistance in human cancer cells , 2004, Oncogene.

[8]  H. Izumi,et al.  p300/CBP-associated factor (P/CAF) interacts with nuclear respiratory factor-1 to regulate the UDP-N-acetyl-alpha-d-galactosamine: polypeptide N-acetylgalactosaminyltransferase-3 gene. , 2003, The Biochemical journal.

[9]  H. Uramoto,et al.  Physical interaction of tumour suppressor p53/p73 with CCAAT-binding transcription factor 2 (CTF2) and differential regulation of human high-mobility group 1 (HMG1) gene expression. , 2003, The Biochemical journal.

[10]  R. Behringer,et al.  Twist function is required for the morphogenesis of the cephalic neural tube and the differentiation of the cranial neural crest cells in the mouse embryo. , 2002, Developmental biology.

[11]  Takayuki Kuroda,et al.  Common Regulation of Growth Arrest and Differentiation of Osteoblasts by Helix-Loop-Helix Factors , 2001, Molecular and Cellular Biology.

[12]  M. Baylies,et al.  Dimerization partners determine the activity of the Twist bHLH protein during Drosophila mesoderm development. , 2001, Development.

[13]  Y Iwamoto,et al.  Interaction with p53 Enhances Binding of Cisplatin-modified DNA by High Mobility Group 1 Protein* , 2001, The Journal of Biological Chemistry.

[14]  H. Uramoto,et al.  Y box-binding protein-1 binds preferentially to single-stranded nucleic acids and exhibits 3'-->5' exonuclease activity. , 2001, Nucleic acids research.

[15]  L. Kedes,et al.  Twist is a potential oncogene that inhibits apoptosis. , 1999, Genes & development.

[16]  L. Kedes,et al.  Regulation of Histone Acetyltransferases p300 and PCAF by the bHLH Protein Twist and Adenoviral Oncoprotein E1A , 1999, Cell.

[17]  S. Berger,et al.  p53 Sites Acetylated In Vitro by PCAF and p300 Are Acetylated In Vivo in Response to DNA Damage , 1999, Molecular and Cellular Biology.

[18]  C. Prives,et al.  High mobility group protein-1 (HMG-1) is a unique activator of p53. , 1998, Genes & development.

[19]  L. Kedes,et al.  The basic domain of myogenic basic helix-loop-helix (bHLH) proteins is the novel target for direct inhibition by another bHLH protein, Twist , 1997, Molecular and cellular biology.

[20]  A. Yang,et al.  Monoallelically Expressed Gene Related to p53 at 1p36, a Region Frequently Deleted in Neuroblastoma and Other Human Cancers , 1997, Cell.

[21]  R. Schulz,et al.  Twist-mediated Activation of the NK-4 Homeobox Gene in the Visceral Mesoderm of Drosophila Requires Two Distinct Clusters of E-box Regulatory Elements* , 1997, The Journal of Biological Chemistry.

[22]  M. Tanimoto,et al.  Role of the human Y box-binding protein YB-1 in cellular sensitivity to the DNA-damaging agents cisplatin, mitomycin C, and ultraviolet light. , 1996, Cancer research.

[23]  R. Behringer,et al.  twist is required in head mesenchyme for cranial neural tube morphogenesis. , 1995, Genes & development.

[24]  T. Quertermous,et al.  Cloning and characterization of a basic helix-loop-helix protein expressed in early mesoderm and the developing somites. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Yi-Song Wang,et al.  WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. , 1994, Cancer research.

[26]  B. Thisse,et al.  Sequence of the twist gene and nuclear localization of its protein in endomesodermal cells of early Drosophila embryos. , 1988, The EMBO journal.

[27]  H. Izumi,et al.  Twist promotes tumor cell growth through YB-1 expression. , 2008, Cancer research.

[28]  若杉 哲郎.  ZNF143 interacts with p73 and is involved in cisplatin resistance through the transcriptional regulation of DNA repair genes , 2007 .

[29]  고수일.  Regulation of histone acetyltransferases activity of p300 and PCAF by proto-oncogene protein DEK , 2006 .

[30]  Y. Yoshida,et al.  Cisplatin resistance and transcription factors. , 2005, Current medicinal chemistry. Anti-cancer agents.

[31]  浦本 秀隆.  p73 interacts with c-Myc to regulate Y-box-binding protein-1 expression , 2004 .

[32]  岡本 龍郎.  Direct interaction of p53 with the Y-box binding protein,YB-1 : A mechanism for regulation of human gene expression , 2001 .

[33]  E. Green,et al.  Mutations in TWIST, a basic helix–loop–helix transcription factor, in Saethre-Chotzen syndrome , 1997, Nature Genetics.

[34]  P. Bénit,et al.  Mutations of the TWIST gene in the Saethre-Chotzene syndrome , 1997, Nature Genetics.